Table 1 Baseline characteristics
|  | Overall population (n = 24658) | AF (n = 740) | No AF (n = 23918) | P value |
|---|---|---|---|---|
Demographics | ||||
 Age(years) | 63 (53–72) | 73 (65–79) | 63 (53–72) | <0.01 |
 Men | 74.2 | 64.9 | 74.5 | <0.01 |
Medical history | ||||
 Previous angina pectoris | 28.2 | 32.0 | 28.0 | 0.02 |
 PreviousMI | 7.7 | 7.9 | 7.6 | 0.81 |
 PreviousPCI/CABG | 5.2 | 4.5 | 5.2 | 0.37 |
 Previous heart failure | 2.6 | 7.7 | 2.4 | <0.01 |
 Previous stroke | 9.5 | 17.8 | 9.2 | <0.01 |
 Previous peripheral arterial disease | 0.6 | 1.1 | 0.6 | 0.15 |
 Chronic renal failure | 1.4 | 1.7 | 1.4 | 0.60 |
Cardiovascular risk factors | Â | Â | Â | Â |
 Hypertension | 51.5 | 59.3 | 51.2 | <0.01 |
 Hyperlipidemia | 8.0 | 6.3 | 8.1 | 0.10 |
 Diabetes mellitus | 20.0 | 18.8 | 20.0 | 0.44 |
 Family history of premature CAD | 4.0 | 3.0 | 4.0 | 0.12 |
 Current smoker | 54.7 | 44.7 | 55.0 | <0.01 |
Clinical characteristics | ||||
 STEMI | 75.7 | 65.7 | 76.0 | <0.01 |
 LVEF(%) | 55(47–60) | 50(41–59) | 55(47–60) | <0.01 |
 Killip classification III-IV | 9.2 | 24.2 | 8.7 | <0.01 |
 CHA2DS2-VASc ≥ 2 | 46.1 | 66.1 | 45.5 | <0.01 |
 HAS-BLED ≥ 3 | 11.1 | 21.4 | 10.8 | <0.01 |
 GRACE Score | 129 (112–149) | 161 (133–182) | 129 (112–146) | <0.01 |
 TIMI Score | ||||
 STEMI | 4 (2–6) | 6 (4–8.5) | 4 (2–6) | <0.01 |
 NSTEMI | 2(2–3) | 2(2–3) | 2(1–3) | <0.01 |
Treatments | ||||
 Reperfusion Therapy | 48.0 | 35.9 | 48.3 | <0.01 |
 PCI | 40.2 | 29.7 | 40.5 | <0.01 |
 Fibrinolysis | 7.8 | 6.2 | 7.8 | <0.01 |
 ACE/ARB | 59.7 | 54.8 | 59.9 | 0.02 |
 β-blockers | 69.9 | 59.9 | 70.2 | <0.01 |
 Anti-arrhythmia drugs | 9.8 | 45.4 | 8,7 | <0.001 |